What is Coburn Technologies?
Coburn Technologies stands as a global leader in the design, manufacture, and service of computer-integrated ophthalmic lens processing systems. The company provides a comprehensive suite of tools that facilitate the entire lifecycle of lens production, from surfacing prescriptions in lens blanks to the final coating and finishing processes required for patient frames. Beyond its core manufacturing prowess, the firm has diversified its offerings to include high-precision diagnostic, refraction, and retinal imaging equipment. This holistic approach allows eye care professionals to access integrated solutions that enhance clinical outcomes and operational efficiency. As an American-owned enterprise, Coburn Technologies maintains a strong reputation for engineering excellence and reliable service within the medical device industry.
How much funding has Coburn Technologies raised?
Coburn Technologies has raised a total of $2.1M across 2 funding rounds:
Debt
$1M
Debt
$1.1M
Debt (2020): $1M with participation from PPP
Debt (2021): $1.1M led by PPP
Key Investors in Coburn Technologies
PPP
Public-Private Partnership
What's next for Coburn Technologies?
Looking ahead, the strategic deployment of this capital will likely focus on accelerating the digital transformation of ophthalmic workflows. As the industry shifts toward more automated and software-centric environments, Coburn Technologies is poised to capitalize on the demand for integrated diagnostic and processing systems. The company's roadmap suggests a continued emphasis on R&D to refine its retinal imaging capabilities and expand its reach into emerging markets. By maintaining its focus on high-quality, American-engineered solutions, the firm is expected to sustain its growth trajectory, ensuring that eye care practitioners remain equipped with the most advanced technology available to meet the evolving needs of their patients.
See full Coburn Technologies company page
